125 related articles for article (PubMed ID: 27549433)
1. Increased risk of borderline ovarian tumors in women with a history of pelvic inflammatory disease: A nationwide population-based cohort study.
Rasmussen CB; Jensen A; Albieri V; Andersen KK; Kjaer SK
Gynecol Oncol; 2016 Nov; 143(2):346-351. PubMed ID: 27549433
[TBL] [Abstract][Full Text] [Related]
2. Pelvic Inflammatory Disease and the Risk of Ovarian Cancer and Borderline Ovarian Tumors: A Pooled Analysis of 13 Case-Control Studies.
Rasmussen CB; Kjaer SK; Albieri V; Bandera EV; Doherty JA; Høgdall E; Webb PM; Jordan SJ; Rossing MA; Wicklund KG; Goodman MT; Modugno F; Moysich KB; Ness RB; Edwards RP; Schildkraut JM; Berchuck A; Olson SH; Kiemeney LA; Massuger LF; Narod SA; Phelan CM; Anton-Culver H; Ziogas A; Wu AH; Pearce CL; Risch HA; Jensen A;
Am J Epidemiol; 2017 Jan; 185(1):8-20. PubMed ID: 27941069
[TBL] [Abstract][Full Text] [Related]
3. Pelvic inflammatory disease and risk of invasive ovarian cancer and ovarian borderline tumors.
Rasmussen CB; Faber MT; Jensen A; Høgdall E; Høgdall C; Blaakær J; Kjaer SK
Cancer Causes Control; 2013 Jul; 24(7):1459-64. PubMed ID: 23615817
[TBL] [Abstract][Full Text] [Related]
4. Is Pelvic Inflammatory Disease a Risk Factor for Ovarian Cancer?
Rasmussen CB; Jensen A; Albieri V; Andersen KK; Kjaer SK
Cancer Epidemiol Biomarkers Prev; 2017 Jan; 26(1):104-109. PubMed ID: 27672055
[TBL] [Abstract][Full Text] [Related]
5. Association between pelvic inflammatory disease, infertility, ectopic pregnancy and the development of ovarian serous borderline tumor, mucinous borderline tumor and low-grade serous carcinoma.
Stewart LM; Stewart CJR; Spilsbury K; Cohen PA; Jordan S
Gynecol Oncol; 2020 Mar; 156(3):611-615. PubMed ID: 31983516
[TBL] [Abstract][Full Text] [Related]
6. Risk of uterine, ovarian and breast cancer following pelvic inflammatory disease: a nationwide population-based retrospective cohort study.
Shen CC; Hu LY; Yang AC; Chiang YY; Hung JH; Tsai SJ
BMC Cancer; 2016 Nov; 16(1):839. PubMed ID: 27809870
[TBL] [Abstract][Full Text] [Related]
7. Risk of borderline ovarian tumors among women with benign ovarian tumors: A cohort study.
Guleria S; Jensen A; Kjær SK
Gynecol Oncol; 2018 Jan; 148(1):86-90. PubMed ID: 29174556
[TBL] [Abstract][Full Text] [Related]
8. Risk of high-grade serous ovarian cancer associated with pelvic inflammatory disease, parity and breast cancer.
Stewart LM; Spilsbury K; Jordan S; Stewart C; Holman CDJ; Powell A; Reekie J; Cohen P
Cancer Epidemiol; 2018 Aug; 55():110-116. PubMed ID: 29935395
[TBL] [Abstract][Full Text] [Related]
9. Association of pelvic inflammatory disease (PID) with ovarian cancer: a nationwide population-based retrospective cohort study from Taiwan.
Chang CY; Lin KY; Huang CC; Lin WC
BMC Womens Health; 2021 Jul; 21(1):274. PubMed ID: 34320962
[TBL] [Abstract][Full Text] [Related]
10. Association between pelvic inflammatory disease and risk of ovarian cancer: An updated meta-analysis.
Piao J; Lee EJ; Lee M
Gynecol Oncol; 2020 May; 157(2):542-548. PubMed ID: 32037193
[TBL] [Abstract][Full Text] [Related]
11. Risk of ovarian cancer in women with pelvic inflammatory disease: a population-based study.
Lin HW; Tu YY; Lin SY; Su WJ; Lin WL; Lin WZ; Wu SC; Lai YL
Lancet Oncol; 2011 Sep; 12(9):900-4. PubMed ID: 21835693
[TBL] [Abstract][Full Text] [Related]
12. Association of reproductive factors, oral contraceptive use and selected lifestyle factors with the risk of ovarian borderline tumors: a Danish case-control study.
Huusom LD; Frederiksen K; Høgdall EV; Glud E; Christensen L; Høgdall CK; Blaakaer J; Kjaer SK
Cancer Causes Control; 2006 Aug; 17(6):821-9. PubMed ID: 16783610
[TBL] [Abstract][Full Text] [Related]
13. Pelvic inflammatory disease and the risk of epithelial ovarian cancer.
Risch HA; Howe GR
Cancer Epidemiol Biomarkers Prev; 1995; 4(5):447-51. PubMed ID: 7549798
[TBL] [Abstract][Full Text] [Related]
14. Risk for borderline ovarian tumours after exposure to fertility drugs: results of a population-based cohort study.
Bjørnholt SM; Kjaer SK; Nielsen TS; Jensen A
Hum Reprod; 2015 Jan; 30(1):222-31. PubMed ID: 25376453
[TBL] [Abstract][Full Text] [Related]
15. Pelvic inflammatory disease and risk of ovarian cancer.
Parazzini F; La Vecchia C; Negri E; Moroni S; dal Pino D; Fedele L
Cancer Epidemiol Biomarkers Prev; 1996 Aug; 5(8):667-9. PubMed ID: 8824371
[TBL] [Abstract][Full Text] [Related]
16. Trends in incidence of borderline ovarian tumors in Denmark 1978-2006.
Hannibal CG; Huusom LD; Kjaerbye-Thygesen A; Tabor A; Kjaer SK
Acta Obstet Gynecol Scand; 2011 Apr; 90(4):305-12. PubMed ID: 21306323
[TBL] [Abstract][Full Text] [Related]
17. Risk of epithelial ovarian tumors among women with polycystic ovary syndrome: A nationwide population-based cohort study.
Frandsen CLB; Svendsen PF; Nøhr B; Viuff JH; Maltesen T; Kjaer SK; Jensen A
Int J Cancer; 2023 Sep; 153(5):958-968. PubMed ID: 37357906
[TBL] [Abstract][Full Text] [Related]
18. Pelvic inflammatory disease and risk of epithelial ovarian cancer: a national population-based case-control study in Sweden.
Jonsson S; Jonsson H; Lundin E; Häggström C; Idahl A
Am J Obstet Gynecol; 2024 Jan; 230(1):75.e1-75.e15. PubMed ID: 37778677
[TBL] [Abstract][Full Text] [Related]
19. Borderline ovarian tumors in Denmark 1997-2018: Time trends in incidence by histology, age and educational level.
Baandrup L; Faber MT; Aalborg GL; Kjaer SK
Acta Obstet Gynecol Scand; 2021 Mar; 100(3):436-443. PubMed ID: 33010027
[TBL] [Abstract][Full Text] [Related]
20. Cigarette smoking and risk of epithelial ovarian cancer.
Rossing MA; Cushing-Haugen KL; Wicklund KG; Weiss NS
Cancer Causes Control; 2008 May; 19(4):413-20. PubMed ID: 18080774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
